Clinical Trial

An Exploratory Clinical Study of HRS-4642 in Combination With Immunotherapy and Chemotherapy for Pancreatic Cancer

Name: An Exploratory Clinical Study of HRS-4642 in Combination With Immunotherapy and Chemotherapy for Pancreatic Cancer — clinical trial record (NCT06938282)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

To evaluate the safety and efficacy of HRS-4642 in combination with immunotherapy and chemotherapy in borderline resectable, locally advanced/metastatic pancreatic cancer

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-04-14.

Trial Details

NCT Number	NCT06938282
Lead Sponsor	Shanghai Zhongshan Hospital
Conditions	Pancreatic Cancer
Enrollment	60 participants
Start Date	2025-05-01
Primary Completion	2027-04-30 (estimated)
Study Completion	2029-04-30 (estimated)
Updated on ClinicalTrials.gov	2025-04-25